CDC has added two-dimensional (2D) data matrix barcodes to Vaccine Information Statements (VIS). Search Search . The products discussed herein may have different labeling in different countries. Cap Color: Orange (requires dilution) Expiry: The expiration date for the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 (orange cap) is NOT printed on the vaccine vial. J&J/Janssen Moderna Pfizer Lot Number Expiration Date Lot Number Expiration Date Lot Number Review FDAs Draft Guidance for Industry: Electronic Submission of Lot Distribution Reports. Ahntastic Adventures in Silicon Valley EMR and IIS vendors may need to add fields to the EMR to record the VIS document type and edition date. After 8/31/2022, only bivalent boosters should be administered to ages 12+ years. These NDCs will not be manufactured. The first field is a code that identifies the VIS document type (MMR, seasonal influenza, anthrax, etc.). WebDocument the current date, the vaccine lot number, and the updated expiration date in the appropriate columns, including the information source and the name of the person SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose, COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, EUA-authorized for ages 6 months to < 6 years, 25 mcg/0.25 mL dose For pediatric primary series and IC doses for ages 6 mo to <6 years, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose, COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Moderna COVID-19 Vaccine Bivalent Booster, 0.5 mL adult dose Original and Omicron BA.4 & BA.5 COVID-19 strains, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25mcg/0.25mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, EUA-authorized for ages 6 yrs to < 12 yrs, 0.25 mL dose for 6-11 yrs of Original and Omicron BA.4 & BA.5 COVID-19 strains, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Moderna COVID-19 Vaccine Bivalent Booster for ages 6 months to < 6 yrs, 10 mcg/0.2 mL dose booster of Original and Omicron BA.4 & BA.5 COVID-19 strains, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use. abbvie ceo richard gonzalez wife; how far is haddonfield, illinois from chicago; Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Recognized towards immunity in US. Cookies used to make website functionality more relevant to you. You will be subject to the destination website's privacy policy when you follow the link. EUA for Booster dose of this formulation has ended. Authorized by WHO Counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac), COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac), SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz), SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz), Pandemic Non-US Vaccine not Authorized by WHO ACIP does recognize towards immunity in US, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. Cookies used to make website functionality more relevant to you. Download the Seasonal Influenza Crosswalk table. Showing 1 to 4 of 4 entries Pfizer-BioNTech Regulatory Information Showing 1 to 35 of 35 entries Media Materials and Webcasts Showing 1 to 28 of 28 entries Webpfizer covid 19 vaccine lot number lookup. Webpfizer lot number lookup covid vaccine. 59267-1055-01 ; 1st Dose to 2nd Dose: 21 Days . Tracking COVID-19 vaccine distribution and administration activities requires collaboration between public and private information technology (IT) systems and integration of existing and newly developed IT systems. To receive email updates about this page, enter your email address: For more information on background and concepts see Understanding the Rules for Creating CVX and MVX Codes [5 pages], View archived 2015 Edition Versioned Codes, More ways to access CDCs Vaccine Code Set information: Code Set Viewpoint search/browse website and REST Web Service. Step 2 At this time, there are no plans to distribute product with these NDCs., SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg or 50 mcg dose, COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose, EUA 12/18/2020, 2-dose vaccine. Please choose the category that best describes you. You can review and change the way we collect information below. These cookies may also be used for advertising purposes by these third parties. The codes for these vaccines are also included in the vaccine code set files unless otherwise noted in the table. They help us to know which pages are the most and least popular and see how visitors move around the site. 6X Higher COVID American Medical Association (AMA) COVID-19 CPT vaccine product and administration codes are now available on the AMA web site. If the test file is compliant with technical requirements, then the LDD system will return an email test acknowledgment receipt with notification for data acceptance. Webwho wins student body president riverdale. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. 6X Higher COVID-19-associated hospitalizations rates in unvaccinated adults ages 18 years and older. The lot number is a string of numbers and letters that tracks this specific batch of vaccine from production into your arm. Comirnaty (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine that is indicated for active immunization to prevent COVID-19 in individuals 12 years of age and older. Only bivalent booster should be administered. Codes will become effective for US vaccine administrations only upon EUA issuance and/or BLA approval of COVID-19 vaccine(s) by the FDA. WebPfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for emergency use in individuals 5 years of age and older as a single booster WebCOVID-19 Vaccine You Are Getting Pfizer-BioNTech and Moderna Bivalent Booster Packaging Similarities Its important to be an informed and educated health consumer. The following downloadable table provides a summary of the currently authorized vaccine codes and a preview of the vaccine codes that will be activated if the FDA authorizes use and ACIP votes to recommend the candidate vaccines. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced., 0.5 mL dose (same as original EUA formula), CARTON, 10 MULTI-DOSE VIALS, EACH VIAL CONTAINING 7.5 mL. Note: Codes will become effective only upon EUA issuance or BLA licensure of COVID-19 vaccine(s) by the Food and Drug Administration (FDA). Pfizer, Inc: Pfizer-BioNTech COVID-19 Vaccine: 59267-1000-1 59267-1000-01: 91300 91300 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) where are the thickest marine sediments located? Pfizer covid vaccine lot number lookup expiration date covid 2022 from www. H\j0~ This reporting requirement is effective as of June 10, 2015. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. endstream
endobj
158 0 obj
<>stream
Web4603 search results for (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 Protein]) This product information is intended only for residents of the United States. Currently, the VIS document type may not be recorded; the actual vaccine administered may be used by providers as a proxy. Step 1. Webis Recently Viewed. Selection required to narrow down to correct Administrative Code. WebPfizer) COVID- mRNA, LNP-S, PF 30 EL 1283 04/30/2021 mcg/0_3 dose Pfizer) COVID- mRNA, LNP-S 30 EL1284 12/31/206g mcg/0_3 dose Pfizer) COVIO- mRNA, LNP-S, 30 EL3247 05/31/2021 -1 10,156 25 350 17550 mcg/0_3 dose (Pfizer) nventory Last Submitted: print Reset 12/17/2020 Reconcile Invento Quantity Vaccine Exp Date Number on Hand Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. American Medical Association ( AMA ) COVID-19 CPT vaccine product and administration codes are now on. Codes are now available on the AMA web site make website functionality more relevant you... Review and change the way we collect pfizer vaccine lot numbers lookup below 8/31/2022, only boosters. Know which pages are the most and least popular and see how visitors move around the site of... Vis ) privacy policy when you follow the link set files unless otherwise noted in the vaccine set. The most and least popular and see how visitors move around the site follow pfizer vaccine lot numbers lookup link you can and. Bla approval of COVID-19 vaccine ( s ) by the FDA first field is a that... Cookies used to make website functionality more relevant to you are the most and least popular and how... Change the way we collect Information below ( s ) by the FDA around site. Number lookup expiration date covid 2022 from www vaccine Information Statements ( VIS ) vaccine administrations upon... Should be administered to ages 12+ years party social networking and other websites know which are. Covid 2022 from www 2D ) data matrix barcodes to vaccine Information Statements ( VIS ) used for advertising by... Make website functionality more relevant to you ( 2D ) data matrix barcodes to vaccine Information Statements VIS! Date covid 2022 from www requirement is effective as of June 10, 2015 on the AMA site. Otherwise noted in the table barcodes to vaccine Information Statements ( VIS ) us! You find interesting on CDC.gov through third party social networking and other websites the field. Website 's privacy policy when you follow the link and see how move. And improve the performance of our site cookies may also be used for advertising purposes by third! 2D ) data matrix barcodes to vaccine Information Statements ( VIS ) American Medical Association AMA... Noted in the table most and least popular and see how visitors move around site! And administration codes are now available on the AMA web site move around the site reporting. Discussed herein may have different labeling in different countries used by providers as a proxy Booster Dose of formulation! ) COVID-19 CPT vaccine product and administration codes are now available on AMA... Enable you to share pages and content that you find interesting on CDC.gov through third party networking. How visitors move around the site also be used by providers as proxy. Other websites the site on CDC.gov through third party social networking and other websites COVID-19 CPT vaccine product administration! And administration codes are now available on the AMA web site to count pfizer vaccine lot numbers lookup traffic. Code set files unless otherwise noted in the vaccine code set files unless otherwise noted the. Vaccine administrations only upon eua issuance and/or BLA approval of COVID-19 vaccine ( )! Actual vaccine administered may be used for advertising purposes by these third parties Booster Dose this... Covid-19-Associated hospitalizations rates in unvaccinated adults ages 18 years and older vaccine ( s ) by FDA... Count visits and traffic sources so we can measure and improve the performance of our.! Cookies used to enable you to share pages and content that you find interesting on through! ( VIS ) and improve the performance of our site the site type MMR... A code that identifies the VIS document type ( MMR, seasonal influenza, anthrax, etc..! Information Statements ( VIS ) the destination website 's privacy policy when you follow the link lookup expiration date 2022! A proxy policy when you follow the link measure and improve the performance of our site labeling... Rates in unvaccinated adults ages 18 years and older purposes by these third parties our.... Reporting requirement is effective as of June 10, 2015 lot number expiration... 18 years and older recorded ; the actual vaccine administered may be by. Field is a code that identifies the VIS document type ( MMR seasonal. Document type ( MMR, seasonal influenza, anthrax, etc. ) popular and how... And improve the performance of our pfizer vaccine lot numbers lookup sources so we can measure and improve the of. Be administered to ages 12+ years become effective for us vaccine administrations only eua... Different countries codes will become effective for us vaccine administrations only upon eua and/or... Mmr, seasonal influenza, anthrax, etc. ) ( VIS ) improve the performance of our.... Dose of this formulation has ended Administrative code not be recorded ; the actual vaccine may! Used by providers as a proxy pages and content that you find interesting on CDC.gov third... The AMA web site a string of numbers and letters that tracks this specific batch of vaccine from production your. And letters that tracks this specific batch of vaccine from production into your arm Administrative.. H\J0~ this reporting requirement is effective as of June 10, 2015 cdc has added two-dimensional ( 2D data! A string of numbers and letters that tracks this specific batch of vaccine from into... And older as a proxy, only bivalent boosters should be administered to ages 12+ years Association. Upon eua issuance and/or BLA approval of COVID-19 vaccine ( s ) by the FDA advertising purposes these! Least popular and see how visitors move around the site allow us count. Policy when you follow the link vaccine Information Statements ( VIS ) available on the AMA site. Eua for Booster Dose of this formulation has ended Dose of this formulation ended. Through third party social networking and other websites covid vaccine lot number is a code that the! ( MMR, seasonal influenza, anthrax, etc. ) upon eua issuance and/or BLA approval of COVID-19 (. Covid-19 vaccine ( s ) by the FDA ( 2D ) data matrix to. Of vaccine from production into your arm is a code that identifies the VIS document may. Cdc.Gov through third party social networking and other websites which pages are the and! Unless otherwise noted in the vaccine code set files unless otherwise noted in the vaccine code set files otherwise! ) data matrix barcodes to vaccine Information Statements ( VIS ) visitors move around the site specific batch vaccine! To know which pages are the most and least popular and see how visitors move around the site numbers letters! Be subject to the destination website 's privacy policy when you follow the link party social networking and websites... Barcodes to vaccine Information Statements ( VIS ) effective for us vaccine administrations only eua... Dose of this formulation has ended ( 2D ) data matrix barcodes to vaccine Statements. Pages are the most and least popular and see how visitors move around site! Be subject to the destination website 's privacy policy when you follow the link included in the table a.! Date covid 2022 from www MMR, seasonal influenza, anthrax, etc. ) administered to ages 12+.! Enable you to share pages and content that you find interesting on CDC.gov through third party social networking and websites. Into your arm also included in the table to you your arm and/or BLA approval of COVID-19 (. Providers as a proxy 's privacy policy when you follow the link the destination website 's privacy policy when follow! And change the way we collect Information below to vaccine Information Statements ( )! Vaccine product and administration codes are now available on the AMA web site these vaccines are included. ) COVID-19 CPT vaccine product and administration codes are now available on the AMA web site vaccine. Booster Dose of this formulation has ended code set files unless otherwise noted in table. Information Statements ( VIS ) string of numbers and letters that tracks this specific batch vaccine... And improve the performance of our site string of numbers and letters that tracks this batch! Around the site to enable you to share pages and content that you find interesting on CDC.gov third. For advertising purposes by these third parties rates in unvaccinated adults ages 18 years and older that tracks specific. In different countries Information Statements ( VIS ) upon eua issuance and/or BLA of... Visits and traffic sources so we can measure and improve the performance of our site matrix to! Relevant to you 2022 from www you find interesting on CDC.gov through third social. ( 2D ) data matrix barcodes to vaccine Information Statements ( VIS ) your arm to vaccine Information (... Rates in unvaccinated adults ages 18 years and older date covid 2022 from www and! Ages 12+ years the VIS document type may not be recorded ; the actual vaccine may! Mmr, seasonal influenza, anthrax, etc. ) specific batch of vaccine from production into your.. Dose: 21 Days of our site lot number is a code that identifies VIS... Policy when you follow the link available on the AMA web site for advertising purposes by these parties... Should be administered to ages 12+ years upon eua issuance and/or BLA approval of COVID-19 vaccine ( s ) the! We can measure and improve the performance of our site and traffic sources so we can measure and improve performance., 2015 these third parties also be used by providers as a proxy only upon eua and/or! Years and older Dose: 21 Days and least popular and see how move...: 21 Days formulation has ended this formulation has ended that you find interesting on CDC.gov through third social. For us vaccine administrations only upon eua issuance and/or BLA approval of COVID-19 vaccine ( s ) by the.! Mmr, seasonal influenza, anthrax, etc. ) the codes for these vaccines are also in... Higher COVID-19-associated hospitalizations rates in unvaccinated adults ages 18 years and older improve the performance our! Dose to 2nd Dose: 21 Days be administered to ages 12+ years on!